Venetoclax Combined with Intensive Therapy for Acute Myeloid Leukemia Patients with Lower Early Peripheral Blast Clearance Rate After Standard Induction Therapy
- Status
- RECRUITING
- Phase
- NA
Clinical Trials Related to Venetoclax
Related studies linked through entity extraction aliases.
Efficacy of Venetoclax Combined With Intensive Chemotherapy in Different Subgroups of AML
- Status
- RECRUITING
- Phase
- PHASE2
APVO436 Phase 1b/2 Study in Patients With Newly Diagnosed AML
- Status
- RECRUITING
- Phase
- PHASE1
Daratumumab Combined With Venetoclax and Dexamethasone for Newly Diagnosed Light-Chain Amyloidosis With Translocation (11;14)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Mitoxantrone Hydrochloride Liposome, Standard-dose of Cytarabine and Venetoclax in the Treatment of R/R AML
- Status
- RECRUITING
- Phase
- PHASE2
Mitoxantrone Hydrochloride Liposome in Combination With Cytarabine and Venetoclax Regimen in Newly Diagnosed Elderly AML
- Status
- RECRUITING
- Phase
- PHASE2
Chemotherapy-free Regimen of Venetoclax, Azacitidine Plus Orebatinib (VAO Regimen) for Newly Diagnosed ph+ALL
- Status
- RECRUITING
- Phase
- PHASE2
RIC Allo-HSCT vs. Venetoclax-Based Consolidation in Elderly AML Patients After First CR
- Status
- RECRUITING
- Phase
- PHASE4
A Study to Evaluate S227928 as a Single Agent and in Combination With Venetoclax in Patients With R/R AML, MDS/AML, or CMML
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
The Efficacy of Triple Regimen in Newly Diagnosed AML Patients With FLT3 Mutation
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Phase 2 Study to Evaluate Efficacy of Calaspargase Pegol-mknl and Decitabine Combined With Venetoclax in Pediatric, Adolescent, and Young Adult Patients With Relapsed/Refractory T-cell Acute Lymphoblastic Leukemia (T-ALL) and T- Cell Lymphoblastic Lymphoma (T-LLy)
- Status
- RECRUITING
- Phase
- PHASE2
De-Escalation Study Evaluating Venetoclax and Azacitidine Discontinuation in AML Responding Patients
- Status
- RECRUITING
- Phase
- PHASE2
Blinatumomab Plus Venetoclax Sequenced With Inotuzumab Ozogamicin in Treating B-ALL
- Status
- RECRUITING
- Phase
- PHASE2
A Phase 1B/2A Trial of NADUNOLIMAB in Combination With Azacitidine (With/Without Venetoclax) in Patients With Myelodysplastic Syndrome (MDS) and Acute Myelogenous Leukemia (AML)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Venetoclax for Prevention of Differentiation Syndrom in Acute Promyelocytic Leukemia Patients
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE2/PHASE3
Safety and Efficacy of Venetoclax, Cytarabine and Metformin (VenCM) for Relapsed-Refractory and Induction-Ineligible Acute Myeloid Leukemia
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Evaluate the Effect of Venetoclax on Participants Receiving a Covalent Bruton's Tyrosine Kinase Inhibitor (cBTKi) for First-line Chronic Lymphocytic Leukemia (1L CLL) to Achieve Deep Durable Remissions to Allow Off-treatment Period
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
GATE1: A Multicenter Phase II Study of Pirtobrutinib, Rituximab and Venetoclax Combination Therapy for Patients With Previously Untreated Mantle Cell Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Randomized Phase II Study Of Bruton Tyrosine Kinase Inhibitor With Or Without Venetoclax In Veterans With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
- Status
- RECRUITING
- Phase
- PHASE2
A Study Comparing the Efficacy and Safety of Pola-RCHP-X Versus RCHOP-X and Pola-RCHP in Previously Untreated Patients With DLBCL
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2